![Julie DiCarlo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julie DiCarlo is currently Head-Investor Relations & Communications at Rapport Therapeutics, Inc. since 2024.
Former positions include Senior Director-Corporate Communications at Cubist Pharmaceuticals LLC, Head-Investor & Media Relations at Epizyme, Inc., Senior VP-Investor Relations & Communications at PureTech Health Plc, and Senior Vice President & Head-Communications at Akili, Inc. Education includes undergraduate studies at Towson University.
| Sociétés | Poste | Début |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Investor Relations Contact | 01/02/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| AKILI, INC. | Public Communications Contact | - |
| PURETECH HEALTH PLC | Investor Relations Contact | - |
| EPIZYME, INC. | Investor Relations Contact | - |
| CUBIST PHARMACEUTICALS INC | Public Communications Contact | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Towson University
 Towson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Akili, Inc.
 Akili, Inc. Medical SpecialtiesHealth Technology Operates as a digital medicine company that uses video-game technology and neuroscience to create treatments for cognitive conditions | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
